University of Minnesota. Driven to Discover.
The shortened treatment didn't just come with clinical drawbacks. It also didn't improve antibiotic resistance rates.
Texas reports another local Zika case as DNA vaccine is successful in phase 1 trial.
Also, officials in France, Sweden, Finland, and Germany report more H5N8.
Experts are particularly concerned about the increase in sales of medically important antibiotics.
In other developments, research teams describe viral levels in semen and thrombocytopenia as a complication.
Also, France, Switzerland, and Poland report more H5N8, and France notes low-path H5N1 and H5N9 avian flu.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.